4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-033725
Co-Chief Executive Officer sold 4,595 shares at $3.15 ($14,483)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klee Justin B. Co-Chief Executive Officer | 2025-03-03 | Sale | −4,595 | $3.15 | $14,483 | 3,196,648 | D |
| Open-market sales · 4,595 sh · avg $3.15 · $14,483 | |||||||
Loading xslF345X05/ownership.xml…